Checkpoint Inhibitor Monotherapy in Potentially Trial-Eligible or Trial-Ineligible Patients With Metastatic NSCLC in the German Prospective CRISP Registry Real-World Cohort (AIO-TRK-0315)Frank Griesinger, Dimitri Flieger, Volker Petersen et al.|JTO Clinical and Research Reports|2023Cited by 4
PharmaForumDe Zeng, Druck Ausrüstung Kraft-Druck GmbH, Danxia Lin et al.|Oncology Research and Treatment|2017Cited by 1
PharmaNewsDe Zeng, Druck Ausrüstung Kraft-Druck GmbH, Danxia Lin et al.|Oncology Research and Treatment|2017Cited by 0
PharmaNewsDe Zeng, Druck Ausrüstung Kraft-Druck GmbH, Danxia Lin et al.|Oncology Research and Treatment|2017Cited by 0
Editorial Board / Contents / ImprintDe Zeng, Druck Ausrüstung Kraft-Druck GmbH, Matthias B. Schulze et al.|Oncology Research and Treatment|2017Cited by 0